Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Davì G et al. |
Increased thromboxane metabolites excretion in liver cirrhosis. |
1998 |
Thromb. Haemost. |
pmid:9569186
|
Oosaki R et al. |
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. |
1998 |
Clin. Exp. Allergy |
pmid:9761018
|
Lindström T et al. |
The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures. |
1998 |
J Trauma |
pmid:9783614
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Cullen L et al. |
Selective cyclooxygenase-2 inhibition by nimesulide in man. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808683
|
Praticò D et al. |
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. |
1998 |
Am. J. Respir. Crit. Care Med. |
pmid:9847257
|
McAdam BF et al. |
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9874808
|
Davì G et al. |
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. |
1999 |
Circulation |
pmid:9892587
|